{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:48:10Z","timestamp":1773967690898,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020230","name":"Health Commission of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to evaluate the real-world clinical efficacy and safety of cefepime in treating pediatric community-acquired pneumonia (CAP), comparing it with other broad-spectrum antibiotics, including cefoperazone-sulbactam and meropenem, using a propensity score-matched design.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective, propensity score-matched cohort study was conducted in pediatric patients (0\u201318 years) hospitalized with CAP. Patients treated with cefepime were compared to those treated with cefoperazone-sulbactam or meropenem. Clinical outcomes, microbiological clearance, and adverse events were assessed, and propensity score matching was applied to minimize confounding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 788 patients were included, with 720 in the cefepime group and 68 in the comparator group. Both groups showed comparable clinical efficacy, with no significant differences in symptom resolution, laboratory normalization, or radiographic improvement. Microbiological clearance rates were also similar between the groups. The incidence of adverse events was low in both groups, and no statistically significant difference in adverse events was observed between cefepime and the comparator group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results suggest that cefepime is a clinically effective and well-tolerated alternative to other broad-spectrum antibiotics for pediatric CAP, demonstrating comparable clinical outcomes and safety profiles. These findings support cefepime as a viable empiric therapy option, particularly in settings with limited microbiological diagnostics. Further studies are needed to confirm these results and optimize dosing strategies for pediatric populations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2025.1616184","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T01:46:37Z","timestamp":1750211197000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Real-world efficacy and safety of cefepime for pediatric community-acquired pneumonia: a propensity score-matched study"],"prefix":"10.3389","volume":"15","author":[{"given":"Changxin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudi","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1101\/2024.11.18.624106","article-title":"Spatially Resolved in vivo CRISPR Screen Sequencing via Perturb-DBiT","author":"Baysoy","year":"2024","journal-title":"bioRxiv"},{"key":"B2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00006454-200103000-00033","article-title":"Empiric use of cefepime in the treatment of lower respiratory tract infections in children","volume":"20","author":"Bradley","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1031423","article-title":"Epidemiology and mortality predictors for severe childhood community-acquired pneumonia in ICUs: A retrospective observational study","volume":"11","author":"Cao","year":"2023","journal-title":"Front. Pediatr."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1337786","article-title":"Adenovirus and Mycoplasma pneumoniae co-infection as a risk factor for severe community-acquired pneumonia in children","volume":"12","author":"Chen","year":"2024","journal-title":"Front. Pediatr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S1473-3099(17)30396-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015","volume":"17","author":"Collaborators","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"844","DOI":"10.13699\/j.cnki.1001-6821.2014.09.030","article-title":"Guidance for clinical trials of anti-bacterial drugs","volume":"30","year":"2014","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1513\/AnnalsATS.201608-641CME","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia","volume":"13","author":"Erb","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"B9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.idc.2004.07.011","article-title":"Antimicrobial therapy of community-acquired pneumonia","volume":"18","author":"File","year":"2004","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-3728","article-title":"Biomarkers and disease severity in children with community-acquired pneumonia","volume":"145","author":"Florin","year":"2020","journal-title":"Pediatrics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00283-21","article-title":"Bacterial epidemiology and antimicrobial resistance profiles in children reported by the ISPED program in China 2016 to 2020","volume":"9","author":"Fu","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S2213-2600(19)30249-8","article-title":"Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working group","volume":"7","author":"Goodman","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10096-023-04715-5","article-title":"Cefepime versus carbapenems for treatment of AmpC beta-lactamase-producing Enterobacterales bloodstream infections","volume":"43","author":"Herrmann","year":"2024","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v030.i09","article-title":"CEM: Software for coarsened exact matching","volume":"30","author":"Iacus","year":"2009","journal-title":"J. Stat. Softw."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/pan\/mpr013","article-title":"Causal inference without balance checking: Coarsened exact matching","volume":"20","author":"Iacus","year":"2012","journal-title":"Polit. Anal."},{"key":"B16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12028-019-00682-y","article-title":"Clinical, electroencephalographic features and prognostic factors of cefepime-induced neurotoxicity: A retrospective study","volume":"31","author":"Li","year":"2019","journal-title":"Neurocrit. Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.jtho.2020.11.030","article-title":"Using propensity score matching to balance the baseline characteristics","volume":"16","author":"Liang","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/s41587-023-01676-0","article-title":"High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq","volume":"41","author":"Liu","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/IDR.S397513","article-title":"Bacterial epidemiology and antimicrobial resistance profiles of respiratory specimens of children with pneumonia in hainan, China","volume":"16","author":"Mai","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S2214-109X(18)30408-X","article-title":"Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis","volume":"7","author":"McAllister","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1080\/21645515.2017.1371381","article-title":"The etiology of community-acquired pneumonia among children under 5 years of age in mainland China 2001-2015: A systematic review","volume":"13","author":"Ning","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.prrv.2011.11.001","article-title":"Recurrent lower respiratory tract infections in children: a practical approach to diagnosis","volume":"14","author":"Patria","year":"2013","journal-title":"Paediatr. Respir. Rev."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-078489","article-title":"Incidence of community-acquired pneumonia among children under 5 years in Suzhou, China: a hospital-based cohort study","volume":"14","author":"Qian","year":"2024","journal-title":"BMJ Open"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.11.04053","article-title":"Hypoxaemia prevalence and its adverse clinical outcomes among children hospitalised with WHO-defined severe pneumonia in Bangladesh","volume":"11","author":"Rahman","year":"2021","journal-title":"J. Glob. Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2471\/blt.07.048769","article-title":"Epidemiology and etiology of childhood pneumonia","volume":"86","author":"Rudan","year":"2008","journal-title":"Bull. World Health Organ"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1332472","article-title":"Prevalence and resistance characteristics of multidrug-resistant Streptococcus pneumoniae isolated from the respiratory tracts of hospitalized children in Shenzhen, China","volume":"13","author":"Shi","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"8362","DOI":"10.1016\/j.vaccine.2020.11.004","article-title":"Incidence of community-acquired pneumonia in urban China: A national population-based study","volume":"38","author":"Sun","year":"2020","journal-title":"Vaccine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4102\/sajid.v40i1.704","article-title":"Cefepime-induced neurotoxicity","volume":"40","author":"Taylor","year":"2025","journal-title":"S Afr J. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00582-2017","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT)","volume":"50","author":"Torres","year":"2017","journal-title":"Eur. Respir. J."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/20420986251320414","article-title":"Navigating pharmacokinetic and pharmacodynamics challenges of beta-lactam antibiotics in patients with low body weight: efficacy, toxicity, and dosage optimization","volume":"16","author":"Tseng","year":"2025","journal-title":"Ther. Adv. Drug Saf."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1097809","article-title":"Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis","volume":"13","author":"Varona","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12502","article-title":"Development of cefepime-induced encephalopathy in a patient with depression and rectal cancer: A case report","volume":"45","author":"Yamaguchi","year":"2025","journal-title":"Neuropsychopharmacol. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ppul.22608","article-title":"A 4 year prospective study to determine risk factors for severe community acquired pneumonia in children in southern China","volume":"48","author":"Zhang","year":"2013","journal-title":"Pediatr. Pulmonol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1101\/2024.07.28.605493","article-title":"Spatial dynamics of mammalian brain development and neuroinflammation by multimodal tri-omics mapping","author":"Zhang","year":"2024","journal-title":"bioRxiv"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.838790","article-title":"Molecular characterization of penicillin-binding protein2x, 2b and 1a of streptococcus pneumoniae causing invasive pneumococcal diseases in China: A multicenter study","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Microbiol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1616184\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T12:44:11Z","timestamp":1752237851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1616184\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":35,"alternative-id":["10.3389\/fcimb.2025.1616184"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1616184","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"article-number":"1616184"}}